Case 1:
29 year-old male with PMHx significant for Obesity who presents to the ED with complaints of fever, chills, generalized muscle aches, shortness of breath and a nonproductive cough. States symptoms have been present for approximately 5 days.
Vitals: BP: 138/72 HR: 107 SpO2: 88% on 10 LPM RR: 38 Temp: 38.90 PMHx: Obesity
Ht: 5’7”
Wt: 153 kg
Covering Cancer News - Lessons from HealthNewsReview.orgGary Schwitzer
This is 1 of 2 presentations I made at the National Cancer Institute's Cancer Research in the Media workshop for Latin American journalists in Guadalajara on November 7, 2011
Presentation by our Keynote Speaker, Leslie J. Kohman, MD at our Cancer Mission 2020 28th Congressional District Summit in Buffalo, NY. Dr. Kohman is the Professor of Surgery Medical Director at Upstate Cancer Center in Syracuse, NY.
The Hidden Risk That Is Tearing Your Company Apart Acbg 3 30 10leanhealthguru
The ACBG Edge is an process that allows construction companies manage the health and productivity risk of their employees. This complements American Construction Benefits Group\’s Lean Health Insurance Advantage. Together, these construction wellness processes create champion companies in 3 short years.
Covering Cancer News - Lessons from HealthNewsReview.orgGary Schwitzer
This is 1 of 2 presentations I made at the National Cancer Institute's Cancer Research in the Media workshop for Latin American journalists in Guadalajara on November 7, 2011
Presentation by our Keynote Speaker, Leslie J. Kohman, MD at our Cancer Mission 2020 28th Congressional District Summit in Buffalo, NY. Dr. Kohman is the Professor of Surgery Medical Director at Upstate Cancer Center in Syracuse, NY.
The Hidden Risk That Is Tearing Your Company Apart Acbg 3 30 10leanhealthguru
The ACBG Edge is an process that allows construction companies manage the health and productivity risk of their employees. This complements American Construction Benefits Group\’s Lean Health Insurance Advantage. Together, these construction wellness processes create champion companies in 3 short years.
Defending Bawa-Garba: When Healthcare Becomes a CrimeCoda Change
Delivery of safe healthcare currently faces unprecedented challenges in the UK and globally. This arises, at least partly, from a rising involvement of the criminal law in the investigation of medical errors apparently conflicting with the need to respect a "duty of candour". As a result, doctors face enormous pressures in fear of being blamed for medical errors. David Sellu is a consultant surgeon who was convicted for gross negligence manslaughter in late 2013 after the death of a patient in a private hospital.I (@DrJennyVaughan) was the medical lead for a group of David Sellu's friends as we launched a campaign to overturn his conviction. There has never been a successful 'out of time' appeal in this area of the law so we were dealing with almost impossible odds from the start. The positive result was extraordinary, both for David and our whole profession (www.medicalmanslaughter.co.uk). Since these events, I have supported other doctors facing criminal conviction, such as the paediatrician Dr Hadiza Bawa-Garba, through my work with the Doctor's Association UK (DAUK, @TheDA_UK). Thousands of doctors crowd-funded a campaign and successfully overturned a court decision to erase her from the UK medical register. Her case proved to be a lightning rod in the UK for a profession at breaking point. Many healthcare staff are working on critically under-staffed wards and in under-resourced departments, with an increasingly unmanageable workload.
DAUK have since launched a "Learn Not Blame" campaign to improve safety for patients and healthcare professionals. We believe that the involvement of the criminal justice system in these cases often does not allow an appreciation of the interplay of individuals within complex health systems. We also remain particularly concerned that a recent analysis of conviction trends shows an excessive conviction rate of black and minority ethnic (BME) healthcare staff.
Surgery vs IMRT for High Risk Prostate Cancer Debate - ACRO 2015drewzer
American College of Radiation Oncology Annual Meeting, Alexandria, Virginia. Drew Moghanaki, MD, MPH, Hunter Holmes McGuire Veterans Affairs Medical Center, Virginia Commonwealth University
Background. Ionizing radiation could cause negative effects on DNA molecules, which leads mutation and tumorigenesis. Thyroid gland is one of the most radiosensitive organ due to the great oxidative process on their physiological condition. Medical workers have been exposed to radiation during medical image acquisition. The relation between radiation and the increase of thyroid cancer incidence have been studied before, the discussion mostly explain the acute effect of radiation. The aim of this study is to describe the incidence of thyroid nodule on radiation-exposed worker.
Methods. The study was performed in 40 radiation-exposed workers with at least has 5 years working period. We examined using thyroid ultrasonography and blood level of T3, fT4 and TSH.
Result. The incidence of thyroid nodule in radiation-exposed worker is 37.5%, which is higher among female (66%) than in male (29%). Based on the age distribution, most of the nodules were find in workers with age more than 35 years old. According to ultrasonography result and TIRADS scoring, 66.7% of the nodules were benign which categorize as TIRADS 1 and only 33% of the nodules were categorize as moderately suspicious or TIRADS 4.
Conclusion. Radiation-exposed workers have high risk to develop thyroid nodules. This study could be used as basic data to do further evaluation. It is important to perform thyroid screening periodically among them.
5
Cancer
Student Name
University
Professor
Course
Date
Cancer
Cancer is a major cause of morbidity and mortality globally, accounting for 9.5 million deaths as of 2018. Thyroid Cancer is one of the most frequent endocrine malignancies, contributing to 3.4 percent of all cancers in the United States each year Indini et al.(2022). While there has been significant progress in the development of new cancer treatments and the increase in the use of anticancer drugs over the past few years, the side effects of these drugs can be severe and sometimes life-threatening. However, there is still a lack of evidence regarding their efficacy and safety. As a result, it is critical to assess the benefits and risks of these medications before hospitals use them to treat cancer patients. This literature review aims to assess the benefits and risks of anticancer medicines in patients with advanced cancer. This literature study will aid in a deeper understanding of these medications and their prospective usage in cancer care.
Similarities
Methodology
Silaghi et al. (2022) and Bachelard et al. (2021) conducted systematic reviews and meta-analyses to investigate the risks and advantages of anticancer medications in patients with advanced cancer, as well as potential causes of resistance to such treatments. Both investigations looked for clinical trials in English written between the years 2000 through 2021 and followed the PRISMA criteria. Indini et al. (2022) employed a different technique conducting a systematic review of the function of the mTOR and NAD pathways in malignancy treatment, progression, and resistance. This study searched Google Scholar, Scopus, PubMed, and Embase for English language papers published between 2000 through 2021.
Findings
Anticancer medication usage was related to a considerable risk of death in advanced cancer patients, according to Silaghi et al. (2022) and Bachelard et al. (2021). However, the authors discovered that these medications were linked to a considerable increase in the likelihood of surviving for at least a year. Furthermore, the researchers discovered that using these medications was related to a considerable increase in the likelihood of living for more than five years. Their findings differed significantly from those of Indini et al. (2022), who discovered that the mTOR and NAD paths are responsible for drug resistance in malignant cells. Furthermore, the authors discovered that these pathways might be possible targets for future treatment methods.
Recommendations
Targeted therapy is recommended by Bachelard et al. (2021), Indini et al. (2022), and Silaghi et al. (2022) as potential therapeutic choices for individuals with advanced cancer who have completed standard-of-care treatment. They also emphasize the necessity of knowing medication resistance mechanisms to design more effective targeted therapeutics. Furthermore, they underline the need for trustworthy biomarkers in guiding treatment deci.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
More Related Content
Similar to Imaging, Overtesting, and Overuse; Just How Dangerous Is It?.pdf
Defending Bawa-Garba: When Healthcare Becomes a CrimeCoda Change
Delivery of safe healthcare currently faces unprecedented challenges in the UK and globally. This arises, at least partly, from a rising involvement of the criminal law in the investigation of medical errors apparently conflicting with the need to respect a "duty of candour". As a result, doctors face enormous pressures in fear of being blamed for medical errors. David Sellu is a consultant surgeon who was convicted for gross negligence manslaughter in late 2013 after the death of a patient in a private hospital.I (@DrJennyVaughan) was the medical lead for a group of David Sellu's friends as we launched a campaign to overturn his conviction. There has never been a successful 'out of time' appeal in this area of the law so we were dealing with almost impossible odds from the start. The positive result was extraordinary, both for David and our whole profession (www.medicalmanslaughter.co.uk). Since these events, I have supported other doctors facing criminal conviction, such as the paediatrician Dr Hadiza Bawa-Garba, through my work with the Doctor's Association UK (DAUK, @TheDA_UK). Thousands of doctors crowd-funded a campaign and successfully overturned a court decision to erase her from the UK medical register. Her case proved to be a lightning rod in the UK for a profession at breaking point. Many healthcare staff are working on critically under-staffed wards and in under-resourced departments, with an increasingly unmanageable workload.
DAUK have since launched a "Learn Not Blame" campaign to improve safety for patients and healthcare professionals. We believe that the involvement of the criminal justice system in these cases often does not allow an appreciation of the interplay of individuals within complex health systems. We also remain particularly concerned that a recent analysis of conviction trends shows an excessive conviction rate of black and minority ethnic (BME) healthcare staff.
Surgery vs IMRT for High Risk Prostate Cancer Debate - ACRO 2015drewzer
American College of Radiation Oncology Annual Meeting, Alexandria, Virginia. Drew Moghanaki, MD, MPH, Hunter Holmes McGuire Veterans Affairs Medical Center, Virginia Commonwealth University
Background. Ionizing radiation could cause negative effects on DNA molecules, which leads mutation and tumorigenesis. Thyroid gland is one of the most radiosensitive organ due to the great oxidative process on their physiological condition. Medical workers have been exposed to radiation during medical image acquisition. The relation between radiation and the increase of thyroid cancer incidence have been studied before, the discussion mostly explain the acute effect of radiation. The aim of this study is to describe the incidence of thyroid nodule on radiation-exposed worker.
Methods. The study was performed in 40 radiation-exposed workers with at least has 5 years working period. We examined using thyroid ultrasonography and blood level of T3, fT4 and TSH.
Result. The incidence of thyroid nodule in radiation-exposed worker is 37.5%, which is higher among female (66%) than in male (29%). Based on the age distribution, most of the nodules were find in workers with age more than 35 years old. According to ultrasonography result and TIRADS scoring, 66.7% of the nodules were benign which categorize as TIRADS 1 and only 33% of the nodules were categorize as moderately suspicious or TIRADS 4.
Conclusion. Radiation-exposed workers have high risk to develop thyroid nodules. This study could be used as basic data to do further evaluation. It is important to perform thyroid screening periodically among them.
5
Cancer
Student Name
University
Professor
Course
Date
Cancer
Cancer is a major cause of morbidity and mortality globally, accounting for 9.5 million deaths as of 2018. Thyroid Cancer is one of the most frequent endocrine malignancies, contributing to 3.4 percent of all cancers in the United States each year Indini et al.(2022). While there has been significant progress in the development of new cancer treatments and the increase in the use of anticancer drugs over the past few years, the side effects of these drugs can be severe and sometimes life-threatening. However, there is still a lack of evidence regarding their efficacy and safety. As a result, it is critical to assess the benefits and risks of these medications before hospitals use them to treat cancer patients. This literature review aims to assess the benefits and risks of anticancer medicines in patients with advanced cancer. This literature study will aid in a deeper understanding of these medications and their prospective usage in cancer care.
Similarities
Methodology
Silaghi et al. (2022) and Bachelard et al. (2021) conducted systematic reviews and meta-analyses to investigate the risks and advantages of anticancer medications in patients with advanced cancer, as well as potential causes of resistance to such treatments. Both investigations looked for clinical trials in English written between the years 2000 through 2021 and followed the PRISMA criteria. Indini et al. (2022) employed a different technique conducting a systematic review of the function of the mTOR and NAD pathways in malignancy treatment, progression, and resistance. This study searched Google Scholar, Scopus, PubMed, and Embase for English language papers published between 2000 through 2021.
Findings
Anticancer medication usage was related to a considerable risk of death in advanced cancer patients, according to Silaghi et al. (2022) and Bachelard et al. (2021). However, the authors discovered that these medications were linked to a considerable increase in the likelihood of surviving for at least a year. Furthermore, the researchers discovered that using these medications was related to a considerable increase in the likelihood of living for more than five years. Their findings differed significantly from those of Indini et al. (2022), who discovered that the mTOR and NAD paths are responsible for drug resistance in malignant cells. Furthermore, the authors discovered that these pathways might be possible targets for future treatment methods.
Recommendations
Targeted therapy is recommended by Bachelard et al. (2021), Indini et al. (2022), and Silaghi et al. (2022) as potential therapeutic choices for individuals with advanced cancer who have completed standard-of-care treatment. They also emphasize the necessity of knowing medication resistance mechanisms to design more effective targeted therapeutics. Furthermore, they underline the need for trustworthy biomarkers in guiding treatment deci.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
12. Who is at fault?
Academic Emergency Medicine, Volume: 22, Issue: 4, Pages: 390-398, First published: 23 March 2015, DOI: (10.1111/acem.12625)
13. Who is at fault?
Academic Emergency Medicine, Volume: 22, Issue: 4, Pages: 390-398, First published: 23 March 2015, DOI: (10.1111/acem.12625)
ME
Y’ALL
21. Lancet 2012; 380: 499–505
Of 10,000 people age 0 to 20 CT scanned
Leukemia (1 scan): 0.83 excess cases
Brain tumors (2-3 scans): 0.32 excess cases
22. Retrospective cohort study: 178,604 children
3x risk of
Leukemia for cumulative doses ~50 mGy
Brain cancer for ~ 60 mGy
23. Absolute vs relative risk: 3x small = still small!
1 excess leukemia and 1 excess brain tumor per
10,000 in first 10 yrs after pediatric head CT
24. BEIR-VII Lifetime Attributable Risk (LAR)
of radiation-induced cancer above baseline
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
0 10 20 30 40 50 60 70 80
Age at Exposure
LAR
(%
per
100
mSv) Female Cancer Incidence
Male Cancer Incidence
Sodickson, Baeyens, Prevedello, et. al. RecurrentCT, Cumulative Radiation Exposure, and Associated Radiation-Induced Cancer Risk from CT of Adults, Radiology. 2009;251(1)
25. Who are we worried about?
31,462 patients
33% > 5 exams
5% > 22 exams
1% > 38 exams
Mean 6.1 exams
Max 132 exams
Sodickson, Baeyens, Prevedello, et. al. RecurrentCT, Cumulative Radiation Exposure, and Associated Radiation-Induced Cancer Risk from CT of Adults, Radiology. 2009;251(1)
asodickson@bwh.harvard.edu
26. Sodickson, Baeyens, Prevedello, et. al. RecurrentCT, Cumulative Radiation Exposure, and Associated Radiation-Induced Cancer Risk from CT of Adults, Radiology. 2009;251(1)
Incremental risks vs benefits (indications)
asodickson@bwh.harvard.edu
27. Sodickson, Baeyens, Prevedello, et. al. RecurrentCT, Cumulative Radiation Exposure, and Associated Radiation-Induced Cancer Risk from CT of Adults, Radiology. 2009;251(1)
Incremental risks vs benefits (indications)
asodickson@bwh.harvard.edu
Patient FP - Cumulative Exposure and LAR
at 1 X, 1/2 X, 1/4 X Projected CT Rates
0
250
500
750
1000
1250
1500
1750
2000
2250
2500
2750
3000
3250
3500
3750
4000
25 30 35 40 45 50 55 60 65 70 75 80
Age
Cumulative
Exposure
(mSv)
0
5
10
15
20
25
%
Lifetime
Attributable
Risk
(LAR)
above
baseline
31. Do we hurt kidneys?
Contrast CT scan à acute kidney injury (AKI)
contrast is
associated
with AKI
contrast not
associated
with AKI
Aycock RD et al. Acute kidney injury after computed tomography: A meta-analysis. Ann Emerg Med 2017 Aug
32. Do we hurt kidneys?
Contrast CT scan à renal replacement therary
(dialysis or similar)
contrast is
associated
with RRT
contrast not
associated
with RRT
Aycock RD et al. Acute kidney injury after computed tomography: A meta-analysis. Ann Emerg Med 2017 Aug
33. Do we hurt kidneys?
Contrast CT scan à death
contrast is
associated
with death
contrast not
associated
with death
Aycock RD et al. Acute kidney injury after computed tomography: A meta-analysis. Ann Emerg Med 2017 Aug
34. Do we hurt kidneys?
Contrast CT scan à death
contrast is
associated
with death
contrast not
associated
with death
Aycock RD et al. Acute kidney injury after computed tomography: A meta-analysis. Ann Emerg Med 2017 Aug
50. Why do we over-test?
Academic Emergency Medicine, Volume: 22, Issue: 4, Pages: 390-398, First published: 23 March 2015, DOI: (10.1111/acem.12625)
51. What do we think would reduce
over testing?
Academic Emergency Medicine, Volume: 22, Issue: 4, Pages: 390-398, First published: 23 March 2015, DOI: (10.1111/acem.12625)
67. In review
More care ≠ better
49.999% of us are worse than average
CT scans add up. Not your fault.
68. In review
Contrast not so bad in our setting.
Incidentalomas and ultrasound.
Spending less money may be costly.
Malpractice reform only a little helpful
Culture matters.